H. Jean Khoury, MD

Specialty

Dr. Khoury was awarded the Georgia Cancer Coalition Distinguished Cancer Scholarship which permitted the establishment of the Hematological Disorders Tissue Bank at Emory University.

Titles and Roles

Director, Division of Hematology
Winship Cancer Institute of Emory University
Professor, Department of Hematology and Medical Oncology
Emory University School of Medicine
Hematologist
Bone Marrow and Stem Cell Transplant Center
Leukemia
Lymphoma
Phase I Clinical Trials Unit
Research Program
Discovery and Developmental Therapeutics

Biography

A recipient of the R. Randall Rollins Chair in Oncology, H. Jean Khoury, MD, is an established authority in hematological malignancies, particularly leukemia and myelodysplastic syndromes. Dr. Khoury leads the division of hematology at Winship Cancer Institute of Emory University which treated over 1,900 patients, both malignant and benign cases, in 2013.

Dr. Khoury is board certified in hematology, medical oncology and internal medicine. He is a practicing physician with Emory Healthcare since 2004. He holds memberships with American College of Physicians, American Medical Association, American Society of Blood and Marrow Transplantation, American Society of Clinical Oncology and American Society of Hematology.

Education

Dr. Khoury earned his Medical Degree from the Université Catholique de Louvain in Brussels, Belgium, and then completed his residency in internal medicine at Memorial Medical Center in Savannah, Georgia, and his fellowship in hematology and medical oncology at Washington University in St. Louis, Missouri.

Research

Dr. Khoury's research interests focus on development of new drugs in leukemia and myelodysplasia, and in the identification of genetic markers that predict outcomes in patients with hematological cancers. This data will be used to help physicians individualize therapies including a bone marrow transplant if necessary to prevent relapse following standard chemotherapy.

He has conducted several leukemia and bone marrow transplant clinical trials, including pivotal trials that have led to the approval of drugs such as bosutinib, dasatinib, ponatinib and omacetaxine.

Using a specialized software he designed and developed, Dr. Khoury instituted models of cost-effective care across the inpatient and outpatient services at Emory Healthcare. These models are in line with future healthcare reforms currently planned and will likely serve as benchmarks in this field.

In collaboration with the Center for International Bone Marrow Transplant Research, Dr. Khoury conducted clinical trials investigating impact of specific drugs on outcomes of allogeneic stem cell transplantation.

Publications

Dr. Khoury's research efforts focus on the development of translational trials in leukemia and bone marrow transplantation, and are reflected in over 100 peer-reviewed papers, of which he is first or senior author.

Cascade Link   TOP